These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
2. Homocysteine, a new cardiovascular risk factor, is also a powerful uremic toxin. Perna AF, Castaldo P, Ingrosso D, De Santo NG. J Nephrol; 1999; 12(4):230-40. PubMed ID: 10493566 [Abstract] [Full Text] [Related]
3. [Homocysteine. The cardiovascular risk factor of the next millennium?]. Suárez García I, Gómez Cerezo JF, Ríos Blanco JJ, Barbado Hernández FJ, Vázquez Rodríguez JJ. An Med Interna; 2001 Apr; 18(4):211-7. PubMed ID: 11496543 [Abstract] [Full Text] [Related]
4. Clinical use and rational management of homocysteine, folic acid, and B vitamins in cardiovascular and thrombotic diseases. Stanger O, Herrmann W, Pietrzik K, Fowler B, Geisel J, Dierkes J, Weger M. Z Kardiol; 2004 Jun; 93(6):439-53. PubMed ID: 15252738 [Abstract] [Full Text] [Related]
15. Homocysteine and coronary heart disease: a review of the current evidence. Pasceri V, Willerson JT. Semin Interv Cardiol; 1999 Sep; 4(3):121-8. PubMed ID: 10545618 [Abstract] [Full Text] [Related]
18. Mechanisms of homocysteine toxicity in humans. Perła-Kaján J, Twardowski T, Jakubowski H. Amino Acids; 2007 Sep; 32(4):561-72. PubMed ID: 17285228 [Abstract] [Full Text] [Related]
19. No evidence for oxidative stress as a mechanism of action of hyperhomocysteinemia in humans. Huerta JM, González S, Fernández S, Patterson AM, Lasheras C. Free Radic Res; 2004 Nov; 38(11):1215-21. PubMed ID: 15621699 [Abstract] [Full Text] [Related]